Long noncoding RNAs and their complex role in shaping and regulating arachidonic acid metabolism: Learning to love the (not-really) junk

被引:1
作者
Desind, Samuel Z. [1 ,2 ]
Bell, Samira K. [1 ,2 ]
Davidson, Zachary M. [1 ,2 ]
Lutz, Carol S. [1 ,2 ,3 ,4 ]
机构
[1] Univ Med & Dent New Jersey, Dept Microbiol Biochem & Mol Genet, Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA
[2] Rutgers Sch Grad Studies, Newark, NJ USA
[3] Rutgers Biomed & Hlth Sci New Jersey Med Sch, Dept Microbiol, Biochem & Mol Genet, Newark, NJ 07103 USA
[4] Rutgers Sch Grad Studies, Newark, NJ 07103 USA
关键词
arachidonic acid; COX-2; inflammatory signaling; long noncoding RNA; miRNA; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NF-KAPPA-B; MESSENGER-RNA; PROSTAGLANDIN SYNTHASE; COX-2; EXPRESSION; GASTROINTESTINAL TOXICITY; HEPATOCELLULAR-CARCINOMA; PROMOTES PROLIFERATION; UP-REGULATION; CANCER;
D O I
10.1002/wrna.1828
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Long noncoding RNAs (lncRNAs) have emerged as critical regulators in numerous biological processes. The arachidonic acid (AA) metabolic pathway is a fundamental biochemical pathway responsible for the enzymatic conversion of AA, a 20-carbon omega-six polyunsaturated fatty acid, into a variety of potent lipid signaling molecules known as eicosanoids. Eicosanoids are produced through the cyclooxygenase and lipoxygenase arms of the AA pathway and have diverse biological roles in both healthy and disease states, including cancer and inflammatory diseases. Cyclooxygenase 2 (COX-2), the inducible, rate-limiting enzyme of the cyclooxygenase arm, produces two main forms of eicosanoids: prostaglandins and thromboxanes. AA metabolized through the lipoxygenase arm by the action of 5-lipoxygenase (ALOX5) produces eicosanoids known as leukotrienes. COX-2 and ALOX5 gene expression are regulated through many different lncRNAs and microRNA (miRNA)-mediated mechanisms. As previously reviewed, noncoding RNAs affect transcription, splicing, alternative polyadenylation, messenger RNA stability, translation, and miRNA regulation of COX-2 and ALOX5 (Lutz and Cornett, 2013, Wiley Interdisciplinary Reviews. RNA, 4(5), 593-605). This current review discusses the intricate roles of lncRNAs, including MALAT1, NEAT1, HOTAIR, PACER, and others, in modulating the AA pathway. In this review update, we will delve into advancements in our understanding of AA gene expression regulation. We will explore the mechanisms of lncRNAs and their associated miRNAs and proteins known to regulate key components of the AA signaling pathway. We will also discuss the therapeutic potential of targeting lncRNA-mediated regulation, with a focus on modulating COX-2 and ALOX5 activity and downstream eicosanoid production for applications in inflammatory and oncological conditions. This article is categorized under: Regulatory RNAs/RNAi/Riboswitches > Regulatory RNAs RNA in Disease and Development > RNA in Disease
引用
收藏
页数:21
相关论文
共 131 条
[1]  
Aloulou A, 2012, METHODS MOL BIOL, V861, P63, DOI 10.1007/978-1-61779-600-5_4
[2]   Interleukin-1β induced Stress Granules Sequester COX-2 mRNA and Regulates its Stability and Translation in Human OA Chondrocytes [J].
Ansari, Mohammad Y. ;
Haqqi, Tariq M. .
SCIENTIFIC REPORTS, 2016, 6
[3]  
Atri C., 2019, AGO-Driven Non-Coding RNAs, V1, P137, DOI DOI 10.1016/B978-0-12-815669-8.00006-3
[4]   NSAIDs in CKD: Are They Safe? [J].
Baker, Megan ;
Perazella, Mark A. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 76 (04) :546-557
[5]   Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective [J].
Bindu, Samik ;
Mazumder, Somnath ;
Bandyopadhyay, Uday .
BIOCHEMICAL PHARMACOLOGY, 2020, 180
[6]   Atherosclerosis: Recent developments [J].
Bjoerkegren, Johan L. M. ;
Lusis, Aldons J. .
CELL, 2022, 185 (10) :1630-1645
[7]   Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis [J].
Blanco, Fernando F. ;
Preet, Ranjan ;
Aguado, Andrea ;
Vishwakarma, Vikalp ;
Stevens, Laura E. ;
Vyas, Alok ;
Padhye, Subhash ;
Xu, Liang ;
Weir, Scott J. ;
Anant, Shrikant ;
Meisner-Kober, Nicole ;
Brody, Jonathan R. ;
Dixon, Dan A. .
ONCOTARGET, 2016, 7 (45) :74043-74058
[8]   Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis [J].
Bobryshev, Yuri V. ;
Ivanova, Ekaterina A. ;
Chistiakov, Dimitry A. ;
Nikiforov, Nikita G. ;
Orekhov, Alexander N. .
BIOMED RESEARCH INTERNATIONAL, 2016, 2016
[9]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[10]   Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial [J].
Bresalier, RS ;
Sandler, RS ;
Quan, H ;
Bolognese, JA ;
Oxenius, B ;
Horgan, K ;
Lines, C ;
Riddell, R ;
Morton, D ;
Lanas, A ;
Konstam, MA ;
Baron, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1092-1102